EPIC | SCLP |
Sector | Pharma and Biotech |
ISIN | GB00B63D3314 |
Market Sector | AIM |
Market Segment | ASQ1 |
Main Indices | FTSE AIM All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £106.27m |
NMS | 20,000 |
Shares in issue | 1,036.78m |
Date Listed | 30-Jul-2010 |
Currency | UK Pounds |
Share Price | 10.25p |
Change Today | 0.25p |
% Change | 2.50 % |
52 Week High | 19.50 |
52 Week Low | 7.50 |
Volume | 409,598 |
Shares Issued | 1,036.78m |
Market Cap | £106.27m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:26 | 3,849 @ 10.29p |
16:13 | 4,179 @ 10.29p |
16:05 | 24,203 @ 10.29p |
15:46 | 41,837 @ 10.29p |
15:05 | 100,000 @ 10.13p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research